Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

19.40 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
MD Anderson and Schrödinger Announce Strategic Research Collaboration to Accelerate Development of WEE1 Program
From Schrödinger, Inc.
Via Business Wire
This Healthcare Company Is Using AI to Develop Drugs
Could this technology be the future of the pharmaceutical industry? 
Via The Motley Fool
Topics Artificial Intelligence Cannabis
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Recap: Schrodinger Q2 Earnings
Shares of Schrodinger (NASDAQ:SDGR) decreased 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 880.00% over... 
Via Benzinga
Schrödinger to Present at Four Investor Conferences in September
From Schrödinger
Via Business Wire
Why Schrödinger Shares Are Rising
Schrödinger Inc (NASDAQ: SDGR) shares are trading higher by 4.8% at $62.58 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced an $82... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
Upgrades For Chatham Lodging Trust (NYSE: 
Via Benzinga
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrodinger, inc (SDGR) Q2 2021 Earnings Call Transcript
SDGR earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Schrödinger Stock Is Trading Lower After Reporting Deeper Than Expected Q2 Loss
Schrödinger Inc (NASDAQ: SDGR) has reported Q2 revenues of $29.78 million, +29% Y/Y, slightly missing the consensus of $29.88 million. Software revenue was $... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) shares rose 20.37% to $3.9 during Thursday's pre-market session. The company's market cap stands at $37.8 million.... 
Via Benzinga
Schrödinger Reports Second Quarter 2021 Financial Results and Provides Company Update
From Schrödinger, Inc.
Via Business Wire
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... 
Via Benzinga
Week In Review: China Life Science Posts $1.3 Billion In Deals
Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome for up to $800 million. Zai Lab and Schrödinger formed a collaboration to develop a... 
Via Talk Markets
Schrödinger, Zai Lab Team Up For Cancer Program Targeting DNA Damage Response
Schrödinger Inc (NASDAQ: SDGR) and Zai Lab Limited (NASDAQ: ZLAB) have collaborated to discover, develop, and commercialize oncology candidate ... 
Via Benzinga
Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncology
From Zai Lab Limited
Via Business Wire
Schrödinger to Host Conference Call to Discuss Second Quarter 2021 Financial Results
From Schrödinger, Inc.
Via Business Wire
Schrödinger Hosts First Annual Educator’s Day and Announces “Teaching with Schrödinger” Program
From Schrödinger, Inc.
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger to Present at Two Virtual Investor Conferences in July
From Schrödinger
Via Business Wire
The 1 Stock I'd Buy Right Now
I'm confident that Schrodinger will be a 10-bagger over the next decade. And it might go up a lot more than that. 
Via The Motley Fool
My Favorite Biotech Stock Right Now
I'm an owner of Schrodinger because this company's software is revolutionizing drug discovery, and it's going to be a monster stock over the next decade. 
Via The Motley Fool
Topics Cannabis
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
4 Penny Stocks With the Potential to Become Top-Notch AI Players
These four penny stocks could get a huge boost from the success of the underlying companies' AI systems going forward. 
Via InvestorPlace
Topics Artificial Intelligence
Schrodinger Insights: Return On Capital Employed
In Q1, Schrodinger (NASDAQ:SDGR) posted sales of $32.13 million. Earnings were up 44.19%, but Schrodinger still reported an overall loss of $23.91 million. In Q4, Schrodinger... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
Schrödinger to Present at Two Investor Healthcare Conferences in June
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrodinger Inc (SDGR) Q1 2021 Earnings Call Transcript
SDGR earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Looking Into Schrodinger's Return On Capital Employed
During Q1, Schrodinger's (NASDAQ:SDGR) reported sales totaled $32.13 million. Despite a 44.19% in earnings, the company posted a loss of $23.91 million. In Q4, Schrodinger brought... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.